Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Margriet Van der Heiden-Van der Loo"'
Autor:
Aimée S. R. Westerveld, Pien Roesthuis, Helena J. H. van der Pal, Dorine Bresters, Marc Bierings, Jacqueline Loonen, Andrica C. H. de Vries, Marloes Louwerens, Maria M. W. Koopman, Marry M. van den Heuvel-Eibrink, Margriet van der Heiden-van der Loo, Peter Hoogerbrugge, Geert O. Janssens, Ronald R. de Krijger, Cecile M. Ronckers, Rob Pieters, Leontien C. M. Kremer, Jop C. Teepen
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Acute lymphoblastic leukemia (ALL) survivors are at risk for developing subsequent neoplasms, but there is limited information on long-term risks and risk factors for both subsequent malignant neoplasms (SMNs) and subsequent non-malignant ne
Externí odkaz:
https://doaj.org/article/dd1578a6e4ab4a39aa7be9fb7ad260a1
Autor:
Adriaan Penson, Iris Walraven, Ewald Bronkhorst, Martha A. Grootenhuis, Wim J. E. Tissing, Helena J. H. van der Pal, Andrica C. H. de Vries, Marry M. van den Heuvel‐Eibrink, Sebastian Neggers, Birgitta A. B. Versluys, Marloes Louwerens, Saskia M. F. Pluijm, Nicole Blijlevens, Margriet van der Heiden‐van der Loo, Leontien C. M. Kremer, Eline van Dulmen‐den Broeder, Hans Knoop, Jacqueline Loonen
Publikováno v:
Cancer Medicine, Vol 11, Iss 4, Pp 1172-1180 (2022)
Abstract Background Fatigue is often reported by patients with childhood cancer both during and after cancer treatment. Several instruments to measure fatigue exist, although none are specifically validated for use in childhood cancer survivors (CCS)
Externí odkaz:
https://doaj.org/article/39033804f7a1457ea0cfc44ce8e284ac
Autor:
Bente M. Houtman, Iris Walraven, Elke de Grouw, Richard W. M. van der Maazen, Leontien C. M. Kremer, Eline van Dulmen-den Broeder, Marry M. van den Heuvel-Eibrink, Wim J. E. Tissing, Dorine Bresters, Helena J. H. van der Pal, Andrica C. H. de Vries, Marloes Louwerens, Margriet van der Heiden-van der Loo, Sebastian J. C. Neggers, Geert O. Janssens, Nicole M. A. Blijlevens, Annechien J. A. Lambeck, Frank Preijers, Jacqueline J. Loonen
Publikováno v:
Journal of Immunology Research, Vol 2023 (2023)
Background. Childhood cancer survivors (CCS) who received radiotherapy involving the spleen or total body irradiation (TBI) might be at risk for splenic dysfunction. A comprehensive screening test for examining splenic dysfunction is lacking. Objecti
Externí odkaz:
https://doaj.org/article/97aeb6763b8e4f25b1e9bd538ec21d67
Autor:
Jan M. Leerink, Elizabeth A. M. Feijen, Perry D. Moerland, Esmee C. de Baat, Remy Merkx, Helena J. H. van der Pal, Wim J. E. Tissing, Marloes Louwerens, Marry M. van den Heuvel‐Eibrink, A. Birgitta Versluys, Folkert W. Asselbergs, Arjan Sammani, Arco J. Teske, Elvira C. van Dalen, Margriet van der Heiden‐van der Loo, Eline van Dulmen‐den Broeder, Andrica C. H. de Vries, Livia Kapusta, Jacqueline Loonen, Yigal M. Pinto, Leontien C. M. Kremer, Annelies M. C. Mavinkurve‐Groothuis, Wouter E. M. Kok
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 14 (2022)
Background Plasma biomarkers may aid in the detection of anthracycline‐related cardiomyopathy (ACMP). However, the currently available biomarkers have limited diagnostic value in long‐term childhood cancer survivors. This study sought to identify
Externí odkaz:
https://doaj.org/article/82e6291c6713455590d77cad399df447
Autor:
Adriaan Penson, Sylvia van Deuren, Ewald Bronkhorst, Ellen Keizer, Tom Heskes, Marieke J. H. Coenen, Judith G. M. Rosmalen, Wim J. E. Tissing, Helena J. H. van der Pal, Andrica C. H. de Vries, Marry M. van den Heuvel-Eibrink, Sebastian Neggers, Birgitta A. B. Versluys, Marloes Louwerens, Margriet van der Heiden-van der Loo, Saskia M. F. Pluijm, Martha Grootenhuis, Nicole Blijlevens, Leontien C. M. Kremer, Eline van Dulmen-den Broeder, Hans Knoop, Jacqueline Loonen
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background A debilitating late effect for childhood cancer survivors (CCS) is cancer-related fatigue (CRF). Little is known about the prevalence and risk factors of fatigue in this population. Here we describe the methodology of the Dutch Ch
Externí odkaz:
https://doaj.org/article/b1bab1f3bbbe4c2189c687dbea2eb226
Autor:
Nina Streefkerk, Wim J E Tissing, Joke C Korevaar, Eline van Dulmen-den Broeder, Dorine Bresters, Margriet van der Heiden-van der Loo, Marry M van de Heuvel-Eibrink, Flora E Van Leeuwen, Jacqueline Loonen, Helena H J van der Pal, Cecile M Ronckers, A Brigitta Versluys, Andrica C H de Vries, Elizabeth A M Feijen, Leontine C M Kremer, Dutch LATER Study Group
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0232708 (2020)
BACKGROUND:Insight in hospitalizations in long-term childhood cancer survivors (CCS) is useful to understand the impact of long-term morbidity. We aimed to investigate hospitalization rates and underlying types of diagnoses in CCS compared to matched
Externí odkaz:
https://doaj.org/article/9dbbb91fee614389a28bba86f3615bf7
Autor:
E. A. M. (Lieke) Feijen, Anna Font‐Gonzalez, Helena J. H. Van der Pal, Wouter E. M. Kok, Ronald B. Geskus, Cécile M. Ronckers, Dorine Bresters, Elvira C. van Dalen, Eline van Dulmen‐den Broeder, Marleen H. van den Berg, Margriet van der Heiden‐van der Loo, Marry M. van den Heuvel‐Eibrink, Flora E. van Leeuwen, Jacqueline J. Loonen, Sebastian J. C. M. M. Neggers, A. B. (Birgitta) Versluys, Wim J. E. Tissing, Leontien C. M. Kremer
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 1 (2019)
Background Heart failure is one of the most important late effects after treatment for cancer in childhood. The goals of this study were to evaluate the risk of heart failure, temporal changes by treatment periods, and the risk factors for heart fail
Externí odkaz:
https://doaj.org/article/10e422f8522e417dbb55c1d0cc39a988
Autor:
Esmee C.M. Kooijmans, Helena J.H. van der Pal, Saskia M.F. Pluijm, Dorine Bresters, Eline van Dulmen-den Broeder, Margriet van der Heiden-van der Loo, Marry M. van den Heuvel-Eibrink, Leontien C.M. Kremer, Jacqueline J. Loonen, Marloes Louwerens, Sebastian J.C. Neggers, Maxime Pilon, Cécile Ronckers, Wim J.E. Tissing, Andrica C.H. de Vries, Gertjan J.L. Kaspers, Arend Bökenkamp, Margreet A. Veening
Publikováno v:
Dutch LATER study group 2022, ' Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2 : Renal study ', European Journal of Cancer, vol. 172, pp. 287-299 . https://doi.org/10.1016/j.ejca.2022.05.038
European Journal of Cancer, 172, 287-299. ELSEVIER SCI LTD
European Journal of Cancer, 172, 287-299. Elsevier Ltd.
European Journal of Cancer, 172, pp. 287-299
European Journal of Cancer, 172, 287-299. Pergamon
European Journal of Cancer, 172, 287-299. Elsevier Limited
European Journal of Cancer, 172, 287-299
European Journal of Cancer, 172, 287-299. ELSEVIER SCI LTD
European Journal of Cancer, 172, 287-299. Elsevier Ltd.
European Journal of Cancer, 172, pp. 287-299
European Journal of Cancer, 172, 287-299. Pergamon
European Journal of Cancer, 172, 287-299. Elsevier Limited
European Journal of Cancer, 172, 287-299
Purpose: To evaluate the prevalence of and risk factors for hypertension in childhood cancer survivors (CCSs) who were treated with potentially nephrotoxic therapies.Methods: In the Dutch Childhood Cancer Survivor Study LATER cohort part 2 renal stud
Autor:
Martha A. Grootenhuis, Wim J. E. Tissing, Dorine Bresters, Marloes van Gorp, Margriet van der Heiden-van der Loo, Cécile M. Ronckers, Anne Maas, Loes M E van Erp, Heleen Maurice-Stam, Leontien C. M. Kremer, Marry M. van den Heuvel-Eibrink, Marloes Louwerens, Jacqueline J. Loonen, Andrica C H de Vries, Gea A. Huizinga, Helena J H van der Pal, Eline van Dulmen-den Broeder
Publikováno v:
Cancer, 128(5), 1074-1084. Wiley
Cancer, 128, 5, pp. 1074-1084
Cancer, 128, 1074-1084
Cancer, 128(5), 1074-1084. John Wiley & Sons Inc.
Cancer, 128, 5, pp. 1074-1084
Cancer, 128, 1074-1084
Cancer, 128(5), 1074-1084. John Wiley & Sons Inc.
Contains fulltext : 248787.pdf (Publisher’s version ) (Open Access) BACKGROUND: The objective of this study was to compare the health-related quality of life (HRQOL) of Dutch adult male and female childhood cancer survivors (CCSs) to general popula
Autor:
Josien G. M. Beijer, Judith L. Kok, Geert O. Janssens, Nina Streefkerk, Andrica C. H. de Vries, Cleo Slagter, John H. Maduro, Petra S. Kroon, Martha A. Grootenhuis, Eline van Dulmen‐den Broeder, Jacqueline J. Loonen, Markus Wendling, Wim J. E. Tissing, Helena J. van der Pal, Marloes Louwerens, Arjan Bel, Jaap den Hartogh, Margriet van der Heiden‐van der Loo, Leontien C. M. Kremer, Jop C. Teepen, Cécile M. Ronckers
Publikováno v:
Cancer Reports, 6, 2
Beijer, J G M, Kok, J L, Janssens, G O, Streefkerk, N, de Vries, A C H, Slagter, C, Maduro, J H, Kroon, P S, Grootenhuis, M A, van Dulmen-den Broeder, E, Loonen, J J, Wendling, M, Tissing, W J E, van der Pal, H J, Louwerens, M, Bel, A, den Hartogh, J, van der Heiden-van der Loo, M, Kremer, L C M, Teepen, J C & Ronckers, C C M 2023, ' Adverse late health outcomes among children treated with 3D radiotherapy techniques : Study design of the Dutch pediatric 3D-RT study ', Cancer reports (Hoboken, N.J.), vol. 6, no. 2, e1620 . https://doi.org/10.1002/cnr2.1620
Cancer Reports, 6(2). WILEY
Cancer Reports, 6
Cancer reports (Hoboken, N.J.), 6(2):e1620. Wiley-Blackwell Publishing Ltd
Beijer, J G M, Kok, J L, Janssens, G O, Streefkerk, N, de Vries, A C H, Slagter, C, Maduro, J H, Kroon, P S, Grootenhuis, M A, van Dulmen-den Broeder, E, Loonen, J J, Wendling, M, Tissing, W J E, van der Pal, H J, Louwerens, M, Bel, A, den Hartogh, J, van der Heiden-van der Loo, M, Kremer, L C M, Teepen, J C & Ronckers, C C M 2023, ' Adverse late health outcomes among children treated with 3D radiotherapy techniques : Study design of the Dutch pediatric 3D-RT study ', Cancer reports (Hoboken, N.J.), vol. 6, no. 2, e1620 . https://doi.org/10.1002/cnr2.1620
Cancer Reports, 6(2). WILEY
Cancer Reports, 6
Cancer reports (Hoboken, N.J.), 6(2):e1620. Wiley-Blackwell Publishing Ltd
Contains fulltext : 291345.pdf (Publisher’s version ) (Open Access) BACKGROUND: Adverse late health outcomes after multimodal treatment for pediatric cancer are diverse and of prime interest. Currently available evidence and survivorship care guide